Science Explorer Back to mapMap
Discussion
Researcher · Sumitomo Dainippon Pharma (Japan) · Japan

Kazuhiko Horigome

Kazuhiko Horigome publishes mostly in Molecular Biology, Immunology and Rheumatology, on topics such as Medical Imaging and Pathology Studies, Heterotopic Ossification and Related Conditions and Monoclonal and Polyclonal Antibodies Research.

OpenAlex
World rank
#1,032,654
of 7,710,434 ranked researchers
Rank in Japan
#14,060
of 383,136
Works
31
Citations
2k
Citations per work
64.5
h-index
19
i10-index 22Top 36% in Molecular Biology
Kazuhiko Horigome

What does Kazuhiko Horigome research?

Kazuhiko Horigome's work is mostly in Medicine (26%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (9%).

Everything else: 14 works · 44.3% of their workLife Sciences: 9 works · 30.0% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 21.1% of their workMolecular Biology: 7 works · 21.1% of their workImmunology and Microbiology: 3 works · 8.9% of their workImmunology: 3 works · 8.9% of their workHealth Sciences: 8 works · 25.7% of their workMedicine: 8 works · 25.7% of their workRheumatology: 2 works · 7.8% of their workPulmonary and Respiratory Medicine: 2 works · 6.7% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 5.6% of their workSurgery: 2 works · 5.6% of their workTHEIR WORKKazuhiko Horigome31works
Life Sciences30%Health Sciences26%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1444.3%
    1. Biochemistry, Genetics and Molecular Biology721.1%
    2. Immunology and Microbiology38.9%
    1. Medicine825.7%
  1. 1Molecular Biology21% of their works
  2. 2Immunology9% of their works
  3. 3Rheumatology8% of their works
  4. 4Pulmonary and Respiratory Medicine7% of their works
  5. 5Surgery6% of their works
  6. 6Radiology, Nuclear Medicine and Imaging6% of their works

Research topics

Which keywords describe Kazuhiko Horigome's research?

The keywords of their largest research topics: Fibrodysplasia Ossificans Progressiva, Heterotopic Ossification, Pulmonary Alveolar Microlithiasis, Pulmonary Sclerosing Hemangioma, Fc Receptors, Therapeutic Antibodies, Immunotoxin and Pancreatic Islets.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Fibrodysplasia Ossificans Progressiva61 topic
  2. Heterotopic Ossification61 topic
  3. Pulmonary Alveolar Microlithiasis61 topic
  4. Pulmonary Sclerosing Hemangioma61 topic
  5. Fc Receptors51 topic
  6. Therapeutic Antibodies51 topic
  7. Immunotoxin41 topic
  8. Pancreatic Islets41 topic
  9. Ricin Poisoning41 topic
  10. ß-Cell Dysfunction41 topic
  11. BDNF31 topic
  12. Cysteamine Therapy31 topic
  13. Cystinosis31 topic
  14. FGF2331 topic
  15. Neurotrophins31 topic
  16. phosphate31 topic

Where does Kazuhiko Horigome work?

Kazuhiko Horigome's main affiliation in the publication record is Sumitomo Dainippon Pharma (Japan), Japan.

How many publications and citations does Kazuhiko Horigome have?

OpenAlex counts 31 works and 2,000 citations for Kazuhiko Horigome, an h-index of 19, ranking #1,032,654 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kazuhiko Horigome. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.